Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

Similar articles for PubMed (Select 21098225)

1.

A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.

Hunzeker JT, Elftman MD, Mellinger JC, Princiotta MF, Bonneau RH, Truckenmiller ME, Norbury CC.

J Immunol. 2011 Jan 1;186(1):183-94. doi: 10.4049/jimmunol.1001737. Epub 2010 Nov 22.

2.

Acquisition of MHC:peptide complexes by dendritic cells contributes to the generation of antiviral CD8+ T cell immunity in vivo.

Smyth LA, Hervouet C, Hayday T, Becker PD, Ellis R, Lechler RI, Lombardi G, Klavinskis LS.

J Immunol. 2012 Sep 1;189(5):2274-82. doi: 10.4049/jimmunol.1200664. Epub 2012 Jul 20.

3.

TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.

Crespo MI, Zacca ER, Núñez NG, Ranocchia RP, Maccioni M, Maletto BA, Pistoresi-Palencia MC, Morón G.

J Immunol. 2013 Feb 1;190(3):948-60. doi: 10.4049/jimmunol.1102725. Epub 2013 Jan 2.

4.

Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.

Farrand KJ, Dickgreber N, Stoitzner P, Ronchese F, Petersen TR, Hermans IF.

J Immunol. 2009 Dec 15;183(12):7732-42. doi: 10.4049/jimmunol.0902707. Epub .

5.

ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.

Duewell P, Kisser U, Heckelsmiller K, Hoves S, Stoitzner P, Koernig S, Morelli AB, Clausen BE, Dauer M, Eigler A, Anz D, Bourquin C, Maraskovsky E, Endres S, Schnurr M.

J Immunol. 2011 Jul 1;187(1):55-63. doi: 10.4049/jimmunol.1004114. Epub 2011 May 25.

6.

Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generation.

Truckenmiller ME, Princiotta MF, Norbury CC, Bonneau RH.

J Neuroimmunol. 2005 Mar;160(1-2):48-60. Epub 2004 Dec 23.

PMID:
15710457
7.

Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.

Kamphorst AO, Guermonprez P, Dudziak D, Nussenzweig MC.

J Immunol. 2010 Sep 15;185(6):3426-35. doi: 10.4049/jimmunol.1001205. Epub 2010 Aug 20.

8.

Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.

Xie Y, Zhang H, Li W, Deng Y, Munegowda MA, Chibbar R, Qureshi M, Xiang J.

J Immunol. 2010 Nov 1;185(9):5268-78. doi: 10.4049/jimmunol.1000386. Epub 2010 Sep 29.

9.

Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.

van Mierlo GJ, Boonman ZF, Dumortier HM, den Boer AT, Fransen MF, Nouta J, van der Voort EI, Offringa R, Toes RE, Melief CJ.

J Immunol. 2004 Dec 1;173(11):6753-9.

10.

Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.

Klotz L, Hucke S, Thimm D, Classen S, Gaarz A, Schultze J, Edenhofer F, Kurts C, Klockgether T, Limmer A, Knolle P, Burgdorf S.

J Immunol. 2009 Jul 1;183(1):129-36. doi: 10.4049/jimmunol.0804260. Epub 2009 Jun 17.

11.

Essential role of endogenous heat shock protein 90 of dendritic cells in antigen cross-presentation.

Ichiyanagi T, Imai T, Kajiwara C, Mizukami S, Nakai A, Nakayama T, Udono H.

J Immunol. 2010 Sep 1;185(5):2693-700. doi: 10.4049/jimmunol.1000821. Epub 2010 Jul 28.

12.

NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.

Stober D, Jomantaite I, Schirmbeck R, Reimann J.

J Immunol. 2003 Mar 1;170(5):2540-8.

13.

Multiple intracellular routes in the cross-presentation of a soluble protein by murine dendritic cells.

Palliser D, Guillen E, Ju M, Eisen HN.

J Immunol. 2005 Feb 15;174(4):1879-87.

15.

Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.

Busche A, Jirmo AC, Welten SP, Zischke J, Noack J, Constabel H, Gatzke AK, Keyser KA, Arens R, Behrens GM, Messerle M.

J Immunol. 2013 Mar 15;190(6):2767-77. doi: 10.4049/jimmunol.1200966. Epub 2013 Feb 6.

16.

Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.

De Veerman M, Heirman C, Van Meirvenne S, Devos S, Corthals J, Moser M, Thielemans K.

J Immunol. 1999 Jan 1;162(1):144-51.

17.

β-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8⁺ T cells.

Liang X, Fu C, Cui W, Ober-Blöbaum JL, Zahner SP, Shrikant PA, Clausen BE, Flavell RA, Mellman I, Jiang A.

J Leukoc Biol. 2014 Jan;95(1):179-90. doi: 10.1189/jlb.0613330. Epub 2013 Sep 10.

18.

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

den Haan JM, Lehar SM, Bevan MJ.

J Exp Med. 2000 Dec 18;192(12):1685-96.

19.

Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1.

Jirmo AC, Nagel CH, Bohnen C, Sodeik B, Behrens GM.

J Immunol. 2009 Jan 1;182(1):283-92.

20.

Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells.

Tagliani E, Guermonprez P, Sepúlveda J, López-Bravo M, Ardavín C, Amigorena S, Benvenuti F, Burrone OR.

J Immunol. 2008 Mar 1;180(5):3201-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk